Introduction
Proteolytic cleavage of complement proteins following activation of the classical, alternative, and lectin pathways can generate substantial quantities of the anaphylatoxin, complement activation fragment (C5a) [1] . Rapid inactivation by carboxypeptidase removes the C-terminal arginine, converting C5a to C5a lacking the C-terminal arginine (C5a desArg ). Both C5a and C5a desArg (with much lower affinity) are ligands for the G-protein coupled C5aR receptor (CD88) [2, 3] . C5aR is abundantly expressed on innate immune cells of the myeloid lineage, lymphocytes, and in lower numbers on epithelial and endothelial cells [4] [5] [6] . In polymorphonuclear leukocytes (PMNs) and macrophages, ligation of C5a with the C5aR receptor leads to rapid buildup of cytosolic Ca 2 + , activation of MAPK signaling pathways, chemotaxis, respiratory burst, release of toxic granules, and regulation of cytokine expression [2, 3, 7] . A second C5a receptor, C5L2 (GPR77), has been identified [8] . Initially, C5a was thought to be a nonsignaling "decoy" receptor [8] . Indeed, binding of C5a or C5a desArg to C5L2 does not induce rapid Ca 2 + currents [9] . However, accumulating evidence suggests distinct functional roles of C5L2 in disease. For example, both C5aR and C5L2 receptors are critical factors during polymicrobial sepsis after cecal ligation and puncture (CLP) [10] . The expression of C5L2 in PMNs is downregulated during severe sepsis, which is a marker of poor prognosis [11] . C5L2 determines the outcome of experimental allergic asthma [12] . Polymorphisms of the C5L2 gene may be associated with a higher risk for cardiovascular diseases in some populations [13] . Despite these findings, many aspects of the role of C5L2 in acute and chronic inflammation remain enigmatic.
In this report, we describe that C5a promotes the release of G-CSF. These effects required the presence of both C5aR and C5L2 in cultures of macrophages and during polymicrobial sepsis after CLP.
Results and discussion

Differential regulation of mediator production by C5a
We have recently reported that the production of several cytokines (IL-17, IL-23, and IL-27) is suppressed by C5a when present in cultures of LPS-activated peritoneal elicited macrophages (PEMs) [5, 14, 15] . To investigate how broad the spectrum of C5a-regulated mediators is, the concentrations of 23 inflammatory mediators were analyzed by a multiplexing bead-based assay ( Table 1) . Incubation of PEMs from C57BL/6J mice with LPS for 10 h generally increased the release of cytokines and chemokines as compared to untreated control PEMs (Table 1) . Simultaneous addition of recombinant mouse C5a (100 nM) to LPS-activated PEMs affected the production of all mediators studied (Table 1) . Although proinflammatory mediators were suppressed by C5a, the remarkable finding was that only IL-10 and G-CSF were amplified (by 103 and 197%, respectively). No consistent effects on production of the analyzed cytokines was observed, when C5a was used alone in PEMs (data not shown; [5, 15] ). It has been reported previously that cytokines of the IL-12 family are antagonized by C5a [16, 17] . Furthermore, we have recently described the role of C5a-induced IL-10 in downmodulation of the IL-17A/IL-23 axis [15] . These findings demonstrate that the strong proinflammatory anaphylatoxin C5a in high concentrations can mediate antiinflammatory effects in primed macrophages, which may be beneficial to prevent excessive inflammation. Reciprocal effects of C5a (as an inducer of proinflammatory cytokines/chemokines) have been noted in other cell types such as alveolar epithelial cells [18] , microvascular endothelial cells [19] , or blood PMNs [20] .
C5a promotes release of G-CSF via Akt and MEK1/2
The current studies were focused on G-CSF, which was the mediator most potently enhanced by C5a in PEMs (Table 1 ). C5a acted dose dependently to increase G-CSF levels by two to threefold in cultures of PEMs (Fig. 1A) . Higher concentrations of G-CSF were observed at all time points (3-24 h) studied (Fig. 1B) . Long-lasting modulation of mediator release by C5a has been also reported for other cytokines [5, 15] . Recombinant C5a desArg in combination with LPS also displayed somewhat diminished ability to amplify G-CSF compared to C5a (Fig. 1C ). C5a enhanced G-CSF production on the mRNA level was detected by real-time PCR (Fig. 1D) .
No effects on G-CSF levels were seen when C5a was used alone in the absence of the co-stimulus, LPS ( Fig. 1C and D) . C5a is known to activate PI3K/Akt and MEK/ERK kinases in innate immune cells [5, 14, 16, [21] [22] [23] . Using bead-based assays with phosphorylation-specific antibodies, we confirmed that C5a activated MEK1 and Akt ( Fig. 1E and F) . These signaling pathways appeared to be relevant for mediating C5a-enhanced G-CSF production. Blockade of PI3K/Akt with the small molecule inhibitor, LY294002, and blockade of MEK1/2 with PD98059 or the highly selective inhibitor, U0126, greatly reduced the release of G-CSF from PEMs activated with LPS or the combination of LPS plus C5a ( Fig. 1G and H) .
G-CSF production is resistant to the inhibitory effects of C5a-induced IL-10
To further elucidate the mechanism by which C5a differentially suppressed proinflammatory cytokines/chemokines, while upregulating G-CSF, we studied the role of IL-10. C5a selectively −/− mice after LPS ± C5a, 8 h, ELISA. All data are shown as mean ± SEM of three to six samples pooled from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, Student's two-tailed t-test.
promoted the production of IL-10 from LPS-activated PEMs (Table 1) . We have recently reported that C5a-induced IL-10 release is essential for suppression of proinflammatory cytokines such as IL-17A and IL-23 by C5a [15] . Interestingly, the release of G-CSF was resistant to the inhibitory effects of recombinant IL-10, even when used in high concentrations (Fig. 1I) . At the same time, proinflammatory cytokines (IL-1β, IL-12, IFN-γ, TNF-α) were greatly reduced by IL-10 (Fig. 1I) . When the production of endogenous IL-10 was interrupted using PEMs from IL-10 −/− mice, no differences were seen in G-CSF production after LPS alone or in combination with C5a (Fig. 1J) . This is in clear contrast to mediators such as IL-12, IL-17A, or IL-23 for which the 
Dependency of G-CSF release in the presence of C5aR and C5L2
There is an ongoing debate on the precise functional roles of the C5L2 receptor as compared to the C5aR receptor [1] . We used PEMs from C5aR −/− mice and C5L2 −/− mice to investigate the roles of both receptors for C5a-mediated amplification of G-CSF. Both C5aR and C5L2 were required for C5a enhancement of G-CSF production in cultures of PEMs from C5aR −/− mice and C5L2 −/− mice ( Fig. 2A) , since the absence of either receptor caused G-CSF levels to fall to baseline levels (with LPS alone).
To study the effects of C5a on G-CSF production during the acute inflammatory response in vivo, we blocked endogenous C5a during endotoxic shock, which resulted in moderately decreased G-CSF (Fig. 2B) . Next, we used the model of polymicrobial sepsis after CLP to study G-CSF production. Sham-operated C57BL/6J mice received only anesthesia and laparotomy without manipulation of the cecum. The amounts of G-CSF in plasma of sham-OP mice were low but G-CSF was greatly increased in C57BL/6J mice 24 h after CLP (>1000 ng/mL, Fig. 2C ). At the same time, plasma concentrations of G-CSF were substantially lower in C5aR −/− mice and C5L2 −/− mice after CLP (Fig. 2C) .
Collectively, it appears that neither C5a receptor (C5aR and C5L2) by itself is able to compensate for the genetic absence of the other receptor, respectively. These findings are quite surprising because C5a does not require presence of the C5L2 receptor (as studied in C5L2 −/− PEMs) for suppression of other cytokines such as IL-17A, IL-23, or IL-27 [5, 14] , suggesting that the effects of C5a on G-CSF production from PEMs are distinct from the regulation of other mediators by C5a (Table 1) . Interestingly, a recent study has reported C5aR internalization after ligand binding and co-localization with intracellular C5L2 in human neutrophils, which may suggest a potential crosstalk of the two receptors [26] . Complement activation is an essential arm of innate immune responses, capable of providing immediate clearance of pathogens by direct lysis (membrane attack complex) and facilitating opsonization/phagocytosis of pathogens. C5a directs chemotaxis of PMNs to the site of inflammation and activates such cells. In addition, our data demonstrate that C5a signaling amplifies the production of G-CSF in vitro and in vivo. G-CSF is a critical growth factor for the proliferation of PMNs during hematopoiesis in the bone marrow. Recombinant G-CSF is an FDA-approved pharmaceutical drug for the treatment of chemotherapy-related severe neutropenia. In one report, C5-deficient mice displayed an impaired mobilization of hematopoietic stem/progenitor cells [27] . C5a promotes the egress of PMNs from the bone marrow into peripheral blood [28] . Our data suggest that C5a via enhanced production of G-CSF may promote the PMN-dependent acute inflammatory response with dependency on both C5aR and C5L2 receptors. Respiratory burst and granule release from PMNs contributes to tissue injury during inflammation (e.g. in the setting of sepsis). In accordance with our findings, the blockade of complement activation using compstatin analogs (which block the C3 convertase) reduced G-CSF levels in human blood during simulated hemodialysis [29] . Moreover, G-CSF appears to upregulate C5aR (CD88) expression on PMNs [28] . In summary, C5a promotes the influx and proliferation of PMNs through multiple mechanisms, whereas different effects are seen with respect to adaptive immunity such as suppression of Th1 and Th17 cytokines.
Concluding remarks
C5a possesses broad-spectrum activities for regulating the release of inflammatory mediators from macrophages. G-CSF is regulated by C5a different than with most other mediators. C5aR and C5L2 are both indispensable for transmission of signaling by C5a in order to amplify G-CSF production in vitro and in vivo.
Materials and methods
Mice
All procedures were in accordance with the U.S. National Institutes of Health guidelines and the University Committee on Use and Care of Animals (UCUCA), University of Michigan. We used male mice of the strains C57BL/6J, IL-10 −/− (B6.129P2-Il10tm1Cgn;
Jackson Laboratories, Bar Harbor, ME, USA), C5aR −/− , and C5L2 −/− (both breeding and genotyping were done at the University of Michigan). Mice were housed under specific pathogen-free conditions. The generation of C5aR −/− and C5L2 −/− mice by targeted gene disruption has been described previously [30, 31] . Animals used were the progeny of at least ten generations of breeding of the knockout mice on the C57BL/6J background.
Cecal ligation and puncture (CLP)
The CLP surgery was performed as described elsewhere [32] . Briefly, mice were anaesthetized with ketamine/xylazine i.p. before laparotomy, ligation of 4-5 mm of the distal cecum with puncture (21-G needle) and postoperative administration of 1 mL 0.9% NaCl subcutaneously. The severity of the procedure was designed to obtain mortality rates of 20-50% after 7 days. Sham mice received anesthetics, laparotomy, and fluid resuscitation without manipulation of the cecum.
Peritoneal elicited macrophages (PEMs)
Thioglycollate (1.5 mL, 2.4%, i.p.) was injected to mice and macrophages (>80% F4/80 + CD11b + ) obtained by peritoneal lavage 4 days later [14] . PEMs were cultured at 2 × 10 6 cells/mL in RPMI 1640 medium supplemented with 100 U/mL penicillinstreptomycin, 0.1% BSA, and 25 mM HEPES at 37
• C and 5% CO 2 .
At the end of experiments, nonadherent cells were pelleted by centrifugation (650 × g, 5 min, 4
• C) and supernatants were stored at −80
• C until further analysis.
Detection of proteins
Mouse G-CSF was quantified by ELISA (R&D Systems) according to the instructions of the manufacturer. Bead-based assays were used for detection of phosphorylated MEK1 (serine 217/serine 221) (BioRad) or phosphorylated Akt (threonine 308) (Millipore). Cells were lysed in the presence of protease and phosphatase inhibitors (Bio-Plex Cell Lysis Kit, BioRad) and assays performed according to instructions of the manufacturers. A multiplex bead-based assay (BioPlex Pro, 23-plex group I, BioRad) was used for simultaneous quantification of the following cytokines/chemokines: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12(p40), IL-12(p70), IL-13, IL-17, eotaxin (CCL11), G-CSF, GM-CSF, IFN-γ, KC (CXCL1), MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β (CCL4), RANTES (CCL5), and TNF-α. All samples from bead-based assays were analyzed on a Luminex-200 instrument as described before [32] .
Real-time PCR
Total RNA was isolated (RNeasy Mini Kit, Qiagen) and reverse transcribed (TaqMen reagents) followed by real-time amplification (SYBR Green Master Mix, Applied Biosystems) on a 7500 Real-Time PCR instrument (Applied Biosystems). The 2 − CT method with normalization to GAPDH and untreated controls was used for calculation of results. Primers for mouse G-CSF (#QT00105140) were purchased from Qiagen. Primer sequences for mouse GAPDH were: (fo) 5 -TACCCCCAATGTGTCCGTCGTG-3 , (re) 5 -CCTTCAGTGGGCCCTCAGATGC-3 .
Reagents
The following reagents were used for the studies: Recombinant mouse C5a (R&D Systems and Hycult); LPS (Escherichia coli, 0111:B4, Sigma-Aldrich); recombinant mouse C5a desArg (Hycult); LY294002 (InvivoGen); PD98059 (InvivoGen); and U0126 (InvivoGen). We used a neutralizing anti-C5a antiserum as described before [14] .
Statistical analysis
The GraphPad Prism Version 5.04 software was used for statistical analysis. All values are expressed as mean and error bars represent SEM. Data sets were analyzed by two-tailed Student's t-test across independent experiments. In vitro experiments were performed independently at least three times and in vivo experiments were done with numbers of mice as indicated in the figure legends. Differences were considered significant when p < 0.05.
